SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000882104-13-000008
Filing Date
2013-05-14
Accepted
2013-05-14 16:01:28
Documents
5
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A pdli-2013331x10qa.htm 10-Q/A 44727
2 CERTIFICATION pdli-2013331x10qaxex311.htm EX-31.1 11330
3 CERTIFICATION pdli-2013331x10qaxex312.htm EX-31.2 11255
4 CERTIFICATION pdli-2013331x10qaxex321.htm EX-32.1 9974
5 pdlilogo.jpg GRAPHIC 7005
  Complete submission text file 0000882104-13-000008.txt   88160
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19756 | Film No.: 13841508
SIC: 2836 Biological Products, (No Diagnostic Substances)